GA
GILD icon

GraniteShares Advisors’s Gilead Sciences GILD Stock Holding History

GraniteShares Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,564
Closed -$275K – 114
2023
Q2 		$275K Sell
3,564
-263
-7% -$21K 0.25% 87
2023
Q1 		$318K Buy
3,827
+18
+0.5% +$1.49K 0.28% 93
2022
Q4 		$327K Sell
3,809
-575
-13% -$45.5K 0.27% 114
2022
Q3 		$270K Sell
4,384
-444
-9% -$28K 0.22% 113
2022
Q2 		$298K Sell
4,828
-958
-17% -$59.3K 0.22% 111
2022
Q1 		$343K Sell
5,786
-466
-7% -$29.8K 0.19% 124
2021
Q4 		$453K Buy
+6,252
New +$431K 0.21% 121

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GraniteShares Advisors's GILD Position: Q3 2023 in Review

GraniteShares Advisors sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 3,564 shares — an estimated $275K sold.

GraniteShares Advisors first reported a position in GILD in Q4 2021 and held it in 7 quarters. The position peaked at $453K in Q4 2021. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • GraniteShares Advisors reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • GraniteShares Advisors sold 3,564 Gilead Sciences shares in Q3 2023, an estimated $275K.
  • GraniteShares Advisors first reported a position in Gilead Sciences in Q4 2021 and held it in 7 quarters.
  • GraniteShares Advisors's Gilead Sciences position peaked at $453K in Q4 2021.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on GraniteShares Advisors's 13F filing for Q3 2023, filed 31 Oct 2023.